Phase 2 Cerebellar Ataxia Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
Spinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 1Huntington Disease
Vico Therapeutics B. V.68 enrolled14 locationsNCT05822908
Not Yet Recruiting
Phase 2Phase 3
Pregabalin for the treatment of Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS) associated chronic cough.
Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS)chronic cough
Richard Roxburgh18 enrolled1 locationACTRN12623001356651
Not Yet Recruiting
Phase 2
A 24-week Open Label, Basket Study of SLS-005 (Trehalose Injection 90.5 mg/mL Intravenous Infusion) in the Treatment of Adults with Neurodegenerative Diseases.
Huntington’s Disease (HD)Spinocerebellar Ataxia Type-3 (SCA3).
Avance Clinical18 enrolled2 locationsACTRN12621001755820